Immune responses to varicella-zoster in the aged - PubMed (original) (raw)
- PMID: 6277260
Free article
Immune responses to varicella-zoster in the aged
B L Burke et al. Arch Intern Med. 1982 Feb.
Free article
Abstract
Skin test reactivity and in vitro lymphocyte stimulation responses to varicella-zoster (VZ) were examined in a large normal population ranging in age from 6 months to 93 years. Warning of cellular immunity, as examined by skin delayed hypersensitivity, began at age 40 years. Skin test responses to phytohemagglutinin, however, remained positive into the eighth decade of life. In vitro lymphocyte stimulation responses to VZ were usually positive (stimulation index greater than or equal to 2.5) until age 60 years, after which time levels, as observed with nonimmune individuals, were often demonstrated. Antibody levels, as measured by fluorescent antibody to membrane antigen, remained positive into the ninth and tenth decades of life. This was especially so with a history of reactivation (zoster) VZ infections, while skin test and in vitro responses were rarely positive in those individuals. This cellular, as contrasted with humoral, immunity decreases with advancing age, which may account for a propensity to reactivation of VZ virus.
Similar articles
- Susceptibility to varicella-zoster virus in Thai children and young adults.
Kositanont U, Wasi C, Oonsombat P, Suvatte V, Thongcharoen P. Kositanont U, et al. Southeast Asian J Trop Med Public Health. 1985 Sep;16(3):414-20. Southeast Asian J Trop Med Public Health. 1985. PMID: 3006266 - Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
Berger R, Luescher D, Just M, D'Hondt E, Bogaert H. Berger R, et al. Postgrad Med J. 1985;61 Suppl 4:137-41. Postgrad Med J. 1985. PMID: 3014471 - Stimulation of specific immune response to varicella antigens in the elderly with varicella vaccine.
Duchateau J, Vrijens R, Nicaise J, D'Hondt E, Bogearts H, Andre FE. Duchateau J, et al. Postgrad Med J. 1985;61 Suppl 4:147-50. Postgrad Med J. 1985. PMID: 3014473 Clinical Trial. - Humoral and cellular immunity to varicella-zoster virus: an overview.
Arvin AM. Arvin AM. J Infect Dis. 2008 Mar 1;197 Suppl 2:S58-60. doi: 10.1086/522123. J Infect Dis. 2008. PMID: 18419410 Review. No abstract available. - Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B. Watson B. J Infect Dis. 2008 Mar 1;197 Suppl 2:S143-6. doi: 10.1086/522130. J Infect Dis. 2008. PMID: 18419388 Review.
Cited by
- The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis.
Hielscher F, Schmidt T, Enders M, Leyking S, Gerhart M, van Bentum K, Mihm J, Schub D, Sester U, Sester M. Hielscher F, et al. EBioMedicine. 2024 Oct;108:105335. doi: 10.1016/j.ebiom.2024.105335. Epub 2024 Sep 11. EBioMedicine. 2024. PMID: 39265505 Free PMC article. - Lipo-pam™ adjuvanted herpes zoster vaccine induces potent gE-specific cellular and humoral immune responses.
Jeong SK, Ham SJ, Baek SH, Jung EJ, Jo HJ, Cha HR, Lee JM, Ahn BC, Yum JS, Chun E. Jeong SK, et al. NPJ Vaccines. 2024 Aug 17;9(1):150. doi: 10.1038/s41541-024-00939-4. NPJ Vaccines. 2024. PMID: 39154056 Free PMC article. - A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates.
Li Y, Tian S, Ai Y, Hu Z, Ma C, Fu M, Xu Z, Li Y, Liu S, Zou Y, Zhou Y, Jin J. Li Y, et al. Front Immunol. 2024 Jul 16;15:1419634. doi: 10.3389/fimmu.2024.1419634. eCollection 2024. Front Immunol. 2024. PMID: 39081325 Free PMC article. - Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination.
Yamaoka-Tojo M, Tojo T. Yamaoka-Tojo M, et al. Vaccines (Basel). 2024 Feb 28;12(3):252. doi: 10.3390/vaccines12030252. Vaccines (Basel). 2024. PMID: 38543886 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources